Targeted Melanoma Screening: Risk Self-Assessment and Skin Self-Examination Education Delivered During Mammography of Women

June K Robinson, Megan Perez, Dalya Abou-El-Seoud, Kathryn Kim, Zoe Brown, Elona Liko-Hazizi, Sarah M Friedewald, Mary Kwasny, Bonnie Spring, June K Robinson, Megan Perez, Dalya Abou-El-Seoud, Kathryn Kim, Zoe Brown, Elona Liko-Hazizi, Sarah M Friedewald, Mary Kwasny, Bonnie Spring

Abstract

Background: Melanoma, which is the sixth most common cancer in women, is visible on the surface of the skin; therefore, self-screening (skin self-examination [SSE]) may be beneficial.

Methods: A convenience sample of women undergoing mammography was sequentially assigned by week into this two-arm targeted melanoma screening intervention. Both groups saw an informational poster and received a brochure promoting risk self-identification and SSE education. One group received an additional 1-week SSE reminder. Participants completed baseline and 1- and 3-month follow-up surveys assessing SSE performance, identifying a concerning mole, scheduling a dermatology appointment, and anxiety due to the program. Performance of SSE between groups was compared using χ2 analysis. The electronic medical record was reviewed for diagnosis of concerning moles.

Results: At 1 month, 384 of 420 (91.4% retention) women completed the survey. Of those, 311 (80.9%) performed SSE. Of those who performed SSE, 54 (14%) found a concerning mole at either 1 or 3 months. At 3 months, 346 (82.4% retention) women completed the survey. The number of women who performed SSE did not differ between groups at 1 month (χ2 = 1.64, P = .17) or 3 months (χ2 = 1.58, P = .12). Seven melanomas were found among 34 women who identified a concerning mole; examination of 4.8 women yielded one melanoma. Anxiety was low with a median score of 9.5 (range = 0-42.9).

Conclusions: Introducing melanoma risks and SSE education during mammography was feasible and did not demonstrate harms; thus, there is an opportunity to reach a large, at-risk population with limited burden for the participant and clinics.

© The Author(s) 2019. Published by Oxford University Press.

Figures

Figure 1.
Figure 1.
CONSORT diagram. The distribution and retention of participants in the two arms of the study are shown.

References

    1. Guy GP Jr, Thomas CC, Thompson T, et al. Vital signs: melanoma incidence and mortality trends and projections—United States, 1982–2030. MMWR Morb Mortal Wkly Rep. 2015;6421:591–596.
    1. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL.. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst. 1996;881:17–23.
    1. Weinstock MA, Martin RA, Risica PM, et al. Thorough skin examination for the early detection of melanoma. Am J Prev Med. 1999;173:169–175.
    1. Kamińska-Winciorek G, Gajda M, Wydmański J, Tukiendorf A.. What do web users know about skin self-examination and melanoma symptoms? Asian Pac J Cancer Prev. 2015;167:3051–3056.
    1. Manne S, Fasanella N, Connors J, Floyd B, Wang H, Lessin S.. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors. Prev Med. 2004;391:36–47.
    1. Robinson JK, Fisher SG, Turrisi RJ.. Predictors of skin self-examination. Cancer. 2002;951:135–146.
    1. Mesters I, Jonkman L, Vasen H, de Vries H.. Skin self-examination of persons from families with familial atypical multiple mole melanoma (FAMMM). Patient Educ Couns. 2009;752:251–255.
    1. Glenn BA, Chen KL, Chang LC, Lin T, Bastani R.. Skin examination practices among melanoma survivors and their children. J Cancer Educ. 2017;322:335–343.
    1. Mujumdar UJ, Hay JL, Monroe-Hinds YC, et al. Sun protection and skin self-examination in melanoma survivors. Psychooncology. 2009;1810:1106–1115.
    1. Johnson MM, Leachman SA, Aspinwall LG, et al. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the USPHSTF controversy. Melanoma Manag. 2017;41:13–37.
    1. US Preventive Services Task Force. Behavioral counseling to prevent skin cancer. JAMA. 2018;31911:1134–1142.
    1. Robinson JK, Wayne JD, Martini MC, Hultgren BA, Mallett KA, Turrisi R.. Early detection of new melanomas by patients with melanoma and their partners using a structured skin self-examination skills training intervention: a randomized clinical trial. JAMA Dermatol. 2016;1529:979–985.
    1. Rzepecki AK, Jain N, Ali Y, et al. Promoting early detection of melanoma during the mammography experience. Int J Womens Dermatol. 2017;34:195–200.
    1. Olsen CM, Pandeya N, Thompson BS, et al. Risk stratification for melanoma: models derived and validated in a purpose-designed prospective cohort. J Natl Cancer Inst. 2018;11010:1075–1083.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG.. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;422:377–381.
    1. Taber JM, Leyva B, Persoskie A.. Why do people avoid medical care? A qualitative study using national data. J Gen Intern Med. 2015;303:290–297.
    1. Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C.. A meta-analysis of nevus-associated melanoma: prevalence and practical implications. J Am Acad Dermatol. 2017;775:938–945.
    1. Geller AC, Emmons KM, Brooks DR, et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer. 2006;1074:806–814.
    1. Glazebrook C, Garrud P, Avery A, Coupland C, Williams H.. Impact of a multimedia intervention “Skinsafe” on patients’ knowledge and protective behaviors. Prev Med. 2006;426:449–454.
    1. Hall IJ. Patterns and trends in cancer screening in the United States. Prev Chronic Dis. 2018;15:E97.
    1. Schueler KM, Chu PW, Smith-Bindman R.. Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health. 2008;179:1477–1498.
    1. Akinlotan M, Bolin JN, Helduser J, et al. Cervical cancer screening barriers and risk factor knowledge among uninsured women. J Community Health. 2017;424:770–778.
    1. Sauer AG, Siegel RL, Jemal A, Fedewa SA.. Updated review of prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;268:1192–1208.
    1. Jones RM, Devers KJ, Kuzel AJ, et al. Patient-reported barriers to colorectal cancer screening. Am J Prev Med. 2010;385:508–516.
    1. Ferrante JM, Shaw EK, Scott JG.. Factors influencing men’s decisions regarding prostate cancer screening: a qualitative study. J Community Health. 2011;365:839–844.
    1. Fleshner K, Carlsson SV, Roobol MJ.. The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nat Rev Urol. 2017;141:26–37.
    1. Delmerico J, Hyland A, Celestino P, et al. Patient willingness and barriers to receiving a CT scan for lung cancer screening. Lung Cancer. 2014;843:307–309.
    1. Ersek JL, Eberth JM, McDonnell KK, et al. Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians. Cancer. 2016;12215:2324–2331.
    1. Coups EJ, Manne SL, Stapleton JL, et al. Skin self-examination behaviors among individuals diagnosed with melanoma. Mel Res. 2016;261:71–76.
    1. Edwards J. Tanning salons in the U.S. IBIS World Industry Report 81219c. Accessed December 7, 2018.
    1. Wernli KJ, Henrikson NB, Morrison CC, et al. Screening for skin cancer in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;3164:436–447.
    1. Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for skin cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;3164:429–435.
    1. American Cancer Society. Skin cancer prevention and early detection. . Accessed December 19, 2018.
    1. Cancer Research UK. Melanoma—screening. . Accessed December 19, 2018.
    1. Cancer Council Australia. Screening for melanoma. . au/about-cancer/types-of-cancer/skin-cancer/melanoma.html. Accessed December 19, 2018.
    1. Moloney FJ, Guitera P, Coates E, et al. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatol. 2014;1508:819–827.
    1. Masri GD, Clark WH Jr, Guerry DT, et al. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990;22(6 Pt 1):1042–1048.
    1. Watts CG, Cust AE, Menzies SW, Mann GJ, Morton RL.. Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of melanoma. J Clin Oncol. 2017;351:63–71.
    1. Welch HG, Black WC.. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;1029:605–661.
    1. Shain AH, Bastian BC.. From melanocytes to melanomas. Nat Rev Cancer. 2016;166:345–358.
    1. Hübner J, Waldmann A, Eisemann N, Noftz M, et al. Association between risk factors and detection of cutaneous melanoma in a setting of a population-based skin cancer screening. Eur J Can Prev. 2018;276:563–569.
    1. Risica PM, Matthews NH, Dionne L, et al. Psychosocial consequences of skin cancer screening. Prev Med Rep. 2018;10:310–316.
    1. Chad-Friedman E, Coleman S, Traeger LN, et al. Psychological distress associated with cancer screening: a systematic review. Cancer. 2017;12320:3882–3894.
    1. Brennan M, Houssami N.. Discussing the benefits and harms of screening mammography. Maturitas. 2016;92:150–153.
    1. Hakama M, Coleman MP, Alexe DM, Auvinen A.. Cancer screening: evidence and practice in Europe 2008. Eur J Cancer. 2008;4410:1404–1413.
    1. Rat C, Dreno B, Nguyen JM.. Why we should focus on melanoma-targeted screening strategies. Dermatology. 2017;2336:480–481.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren